777
Participants
Start Date
December 11, 2012
Primary Completion Date
August 31, 2017
Study Completion Date
August 31, 2026
Edwards Aortic and Mitral Bioprostheses Models 11000A and 11000M
Implant of an aortic valve, Model 11000A or mitral valve, Model 11000M
New York Weill Cornell Medical Center, New York
Mount Sinai Morningside, New York
Icahn School of Medicine at Mount Sinai, New York
New York Presbyterian Hospital - Columbia University Medical Center, New York
Pinnacle Health Cardiovascular Institute, Mechanicsburg
Hospital of the University of Pennsylvania, Philadelphia
University of Maryland, Baltimore, Baltimore
Emory University Hospital Midtown, Atlanta
Shands at the University of Florida, Gainesville
Florida Hospital, Orlando
Cardiology, P.C., Birmingham
Missouri Baptist Medical Center, St Louis
St. Thomas Health, Nashville
North Mississippi Medical Center, Tupelo
OhioHealth Research Institute, Columbus
The Ohio State University Wexner Medical Center, Columbus
Cleveland Clinic Foundation, Cleveland
St. Vincent Heart Center of Indiana, Indianapolis
Spectrum Health Hospital, Grand Rapids
Washington University/ Barnes Jewish Hospital, St Louis
University of Kansas Medical Center, Kansas City
The Heart Hospital of Baylor Plano, Plano
Baylor College of Medicine, Houston
Michael E. DeBakey VA Medical Center, Houston
University of Utah, Salt Lake City
University of Southern California, Los Angeles
Board of Trustees of the Leland Stanford Junior University, Stanford
Sutter Institute for Medical Research, Sacramento
Yale-New Haven, New Haven
Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec
Krakowski Szpital Specjalistyczny im. Jana Pawla II, Krakow
The Cardinal Stefan Wyszynski Institute of Cardiology, Warsaw
Lead Sponsor
Edwards Lifesciences
INDUSTRY